1Karsenty G, Wagner EF. Reaching a genetic and molecular under- standing of skeletal development, Dev Celi,2002,2:389 -406.
2Hotbauer LC, Heufeder AE. Role of receptor activator of nuclear fac- tor -kappa B ligand and osteoprotegerin in bone cell biology. J Mol Med,2001,79(6) :243 -253.
3Sabeti M, Simon V, Kermani Y, et al. Detection of receptor activator of NF - KB ligand in apical periodontitis. J Endodon,2005,31 ( 1 ) : 17 -18.
4Ataoglu T, Ungor M, Serpek B,et al. lnterleukin - 1 beta and Tumor necrosis factor - alpha levels in periapical exudates. Int Endod J, 2002, 35(2) :181 -185.
5Kusano K, Miyaura C, Inada M, et al. Regulation of matrix metallo- proteinases ( MMP - 2, - 3, - 9, and - 13) by interleukin - 1 and interleukin - 6 in mouse calvaria : association of MMP induction with bone resorption. Endocrinol, 1998,139 (3) : 1338 - 1344.
6Wildemann B, Schmidmaier G, Brenner N, et al. Quantification, lo- calization and expression of IGF - 1 and TGF - betal during growth factor- stimulated fracrure healing. Calcif Tissue Int, 2004,74 (4) : 388 - 397.
7Shinoda K, Sugiyama E, Taki H, et al. Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes. Bone,2003,33 (4) :711 -720.
8Wei S, Wang MW, Teitelbaum SL, et al. Interleukin -4 reversibly inhibits osteoclastogenesis via inhibition of NF - KB and mitogen - activated protein kinase signaling. J Biol Chem, 2002,277 ( 8 ) : 6622 - 6630.
